Clinical Trials Logo

Cancer, Hepatocellular clinical trials

View clinical trials related to Cancer, Hepatocellular.

Filter by:
  • None
  • Page 1

NCT ID: NCT06144827 Not yet recruiting - Clinical trials for Radiotherapy Side Effect

A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Start date: June 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the role of quantitative MR imaging and blood-based biomarkers to measure liver function in patients receiving radiation therapy for liver cancer or cancer that has spread to the liver.

NCT ID: NCT04340193 Terminated - Clinical trials for Cancer, Hepatocellular

A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer

CheckMate 74W
Start date: September 15, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of nivolumab with and without ipilimumab in combination with Trans-arterial ChemoEmbolization (TACE) to TACE alone in participants with intermediate liver cancer.

NCT ID: NCT03586050 Completed - Clinical trials for Hepatocellular Carcinoma

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

Start date: December 11, 2017
Phase: N/A
Study type: Interventional

This is a single arm, non-randomized, single center study to evaluate ablation, oncologic outcomes and safety in the treatment of hepatocellular carcinoma.

NCT ID: NCT01929902 Completed - Pancreatectomy Clinical Trials

Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery

Start date: July 2013
Phase:
Study type: Observational

The purpose of this study is to test the efficacy and accuracy of the Aquamantys device.

NCT ID: NCT00669136 Terminated - Clinical trials for Hepatocellular Carcinoma

Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma

Start date: June 2009
Phase: Phase 1
Study type: Interventional

To evaluate the safety, toxicity and immunological effects of adjuvant administration of an experimental therapy consisting on priming with three intramuscular administrations of a plasmid expressing human AFP (phAFP) together with a plasmid expressing human GM-CSF (phGM-CSF), followed by a single intramuscular boost with an AFP adenoviral vector (AdVhAFP) to patients with locoregionally pre-treated hepatocellular carcinoma (HCC).